Spontaneous Vertebral Fractures in Males with Osteoporosis After Denosumab Discontinuation A Report of Two Cases

被引：14
作者：
Anagnostis, Panagiotis [1 ]
Paschou, Stavroula A. [2 ]
Gonzalez-Rodriguez, Elena [3 ]
Potoupnis, Michael [4 ]
Tsiridis, Eleftherios [4 ]
Lamy, Olivier [3 ]
Goulis, Dimitrios G. [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Med Sch, Dept Obstet & Gynecol 1, Unit Reprod Endocrinol, Thessaloniki, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Aghia Sophia Hosp, Div Endocrinol & Diabet, Athens, Greece
[3] Univ Lausanne Hosp SCHUV DAL, Ctr Bone Dis, Lausanne, Switzerland
[4] Aristotle Univ Thessaloniki, Med Sch, Papageorgiou Gen Hosp, C Acad Orthopaed Unit, Thessaloniki, Greece
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2021年 / 27卷 / 8S期
关键词：
POSTMENOPAUSAL WOMEN; BONE LOSS;
D O I：
10.1097/RHU.0000000000000979
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S581 / S584
页数：4
相关论文
共 16 条
  • [1] Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
    Anagnostis, Panagiotis
    Paschou, Stavroula A.
    Mintziori, Gesthimani
    Ceausu, Iuliana
    Depypere, Herman
    Lambrinoudaki, Irene
    Mueck, Alfred
    Perez-Lopez, Faustino R.
    Rees, Margaret
    Senturk, Levent M.
    Simoncini, Tommaso
    Stevenson, John C.
    Stute, Petra
    Tremollieres, Florence A.
    Goulis, Dimitrios G.
    [J]. MATURITAS, 2017, 101 : 23 - 30
  • [2] Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Makras, Polyzois
    Aubry-Rozier, Berengere
    Kaouri, Stella
    Lamy, Olivier
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (06) : 1291 - 1296
  • [3] 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
    Bone, Henry G.
    Wagman, Rachel B.
    Brandi, Maria L.
    Brown, Jacques P.
    Chapurlat, Roland
    Cummings, Steven R.
    Czerwinski, Edward
    Fahrleitner-Pammer, Astrid
    Kendler, David L.
    Lippuner, Kurt
    Reginster, Jean-Yves
    Roux, Christian
    Malouf, Jorge
    Bradley, Michelle N.
    Daizadeh, Nadia S.
    Wang, Andrea
    Dakin, Paula
    Pannacciulli, Nicola
    Dempster, David W.
    Papapoulos, Socrates
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (07) : 513 - 523
  • [4] Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Miller, Paul D.
    Yang, Yu-Ching
    Grazette, Luanda
    San Martin, Javier
    Gallagher, J. Christopher
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) : 972 - 980
  • [5] Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial
    Brown, Jacques P.
    Roux, Christian
    Torring, Ove
    Ho, Pei-Ran
    Jensen, Jens-Erik Beck
    Gilchrist, Nigel
    Recknor, Christopher
    Austin, Matt
    Wang, Andrea
    Grauer, Andreas
    Wagman, Rachel B.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (04) : 746 - 752
  • [6] Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
    Cummings, Steven R.
    Ferrari, Serge
    Eastell, Richard
    Gilchrist, Nigel
    Jensen, Jens-Erik Beck
    McClung, Michael
    Roux, Christian
    Torring, Ove
    Valter, Ivo
    Wang, Andrea T.
    Brown, Jacques P.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (02) : 190 - 198
  • [7] Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
    Freemantle, N.
    Satram-Hoang, S.
    Tang, E. -T.
    Kaur, P.
    Macarios, D.
    Siddhanti, S.
    Borenstein, J.
    Kendler, D. L.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 (01) : 317 - 326
  • [8] Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates
    Horne, Anne M.
    Mihov, Borislav
    Reid, Ian R.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2018, 103 (01) : 55 - 61
  • [9] Underestimation of Vertebral Fractures After Denosumab Discontinuation
    Lamy, Olivier
    Gonzalez-Rodriguez, Elena
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (03) : 547 - 547
  • [10] Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases Report
    Lamy, Olivier
    Gonzalez-Rodriguez, Elena
    Stoll, Delphine
    Hans, Didier
    Aubry-Rozier, Berengere
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (02) : 354 - 358
12